Invest now

Remus Pharmaceuticals Cash Flow Annual

BSE: - | NSE: REMUS | ISIN: INE0O5T01011 | Sector: Biotechnology & Drugs
975.50 -2.75 (-0.28%)Updated : 09 Oct 2026
Research on
Fiscal Period2026202520242023
Period End DateMar 26Mar 25Mar 24Mar 23
Issuance( Retirement)of Debt Net 4.088.75-6.507.75
Net Changein Cash 4.592.5119.031.89
Cash Taxes Paid 9.467.476.573.00
Net Income/ Starting Line 59.1647.3431.8311.41
Total Cash Dividends Paid -1.18-1.18-0.59-
Changesin Working Capital -42.89-40.58-27.45-6.27
Cashfrom Operating Activities 18.426.993.605.31
Cash Interest Paid 1.231.460.480.23
Cashfrom Financing Activities 1.706.0724.3711.77
Depreciation/ Depletion 2.761.870.900.48
Other Investing Cash Flow Items Total -0.47-6.57-8.31-12.46
Capital Expenditures -14.57-3.98-0.64-2.73
period Type ----
Non- Cash Items -0.61-1.64-1.67-0.31
Financing Cash Flow Items -1.20-1.50-16.23-0.23
period Length 12.0012.0012.0012.00
Cashfrom Investing Activities -15.04-10.55-8.94-15.19
Issuance( Retirement)of Stock Net --47.694.25
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,035.00+40.00(4.02%)
1,246.00+17.00(1.38%)
11,400.00-549.00 (-4.59%)